Skip to content

Determination of Posture in Patients With Restrictive and Obstructive Lung Disease

Restriktif ve Obstrüktif Akciğer Hastalıklarında Postür ve Postürle İlişkili Faktörlerin Belirlenmesi

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06306482
Enrollment
90
Registered
2024-03-12
Start date
2024-03-07
Completion date
2026-03-07
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases, Lung Diseases, Obstructive, Postural; Defect

Brief summary

The aim of this study is to determine posture and posture related factors in patients with restrictive and obstructive lung disease.

Detailed description

It is aimed at investigating posture and posture related factors according to both type of disease and severity of disease in patients with restrictive and obstructive lung disease. The secondary purpose is to develop a model that determines correlations between posture and functional exercise capacity, respiratory and peripheral muscle strength, tightness of muscle, balance, and physical activity for each disease that will be included in this study. In accordance with these purposes, for each group, at least 15 patients with obstructive and restrictive lung disease will be included according to the inclusion and exclusion criteria for each disease, and 15 healthy controls will be included. Tests and questionnaires will be used in order to determine the severity of diseases. Lung function test and respiratory and peripheral muscle strength test will be performed. Time and Go test (TUG) and One minute sit to stand test will be performed. To evaluate the accessory respiratory muscles, a muscle tightness test will be performed for each muscle. Six Minute Walk Test (6 MWT) will be performed with an armband that measures energy expenditure for functional exercise capacity. To evaluate posture, the Corbin Postural Assessment Scale and photographic analysis will be used. Photographical analysis using software in lateral, posterior, and anterior views will be used for the cervical, thoracic, and lumbar regions. For angular and length measurements, anatomical landmarks will be determined and calculated in the regions. According to the results to be obtained, changes in posture according to the regions and posture related factors will be determined for each disease. It will guide professional working in this field.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Chronic Obstructive Pulmonary Disease Group Inclusion Criteria: * Over 55 years old, * Stage 1-2-3-4 according to the GOLD, * Being clinically stable for the last 4 weeks. Chronic Obstructive Pulmonary Disease Group

Exclusion criteria

* Receiving long-term oxygen therapy, * Having central and peripheral vestibular disease, * Communication problems, known mental and cognitive problems, * Having undergone any surgical intervention related to the spine within the last six months, Inclusion Criteria for the Cystic Fibrosis Group: * Being diagnosed with CF as a result of two sweat tests, * Being over 18 years old. Cystic Fibrosis Group

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of horizontal alignment of the head anterior view1 dayAngle between left and right tragus and horizontal will be measured via photographic analysis
Evaluation of horizontal alignment of the trunk anterior view1 dayAngle between left and right acromion and horizontal will be measured via photographic analysis Angle between left and right anterior superior iliac spine and horizontal will be measured via photographic analysis. Angle between left and right acromion and left and right anterior superior iliac spine will be measured via photographic analysis.
Evaluation of horizontal alignment of the head lateral view1 dayAngle between left-right tragus and C7 spinous process and horizontal will be measured via photographic analysis.
Evaluation of vertical alignment of the head lateral view1 dayAngle of acromion and tragus (left-right) and vertical will be measured via photographic analysis.
Evaluation of horizontal alignment of the trunk lateral view1 dayAngle between anterior superior iliac spine and posterior superior iliac spina and horizontal will be measured via photographic analysis.
Evaluation of vertical alignment of the trunk lateral view1 dayAngle between acromion and greater trochanter and vertical will be measured via photographic analysis.
Evaluation of horizontal asymmetry trunk in posterior view1 dayHorizontal asymmetry of scapula in relation to T3 spinous process will be measured via photographic analysis.
Evaluation of scapulae1 dayInvestigation of posture by photographic analysis upward rotation/ anterior tilt/internal rotation of scapula, scapular elevation, and scapular abduction evaluations will be measured photographic analysis.
Posture1 dayPosture will be examined via the Corbin Postural Assessment Scale. The total points of the Corbin Postural Assessment Scale range from 0 to 28 points. A higher point represents worse posture.

Secondary

MeasureTime frameDescription
Severity of disease for patients with COPD1 dayGlobal Initiative for Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Pulmonary A,B,E assessment Tool will be used for patients with COPD. According to the Global Initiative for Chronic Obstructive Pulmonary Disease, the severity of airflow limitation (Forced Expiratory Volume in 1 s) was determined as mild (≥ 80%), moderate (50-80%), severe (30-50%), and very severe (\<30%). According to Global Initiative for Chronic Obstructive Pulmonary ABE assessment Tool, patients classified group A, B, and E using symptom status and airflow limitation.
Severity of disease for patients with bronchiectasis1 dayPatients with non- cystic fibrosis bronchiectasis will be classified into three groups according to the Forced Expiratory Volume in 1 s, Age, Chronic colonisation, Extension, Dyspnea level. According to this classification system, patients will be classified as 0-2 points mild, 3-4 moderate, 5-7 severe bronchiectasis.
Functional exercise capacity1 dayFunctional exercise capacity will be determined via Six Minute Walk Test.
Symptoms for patients with COPD1 dayChronic Obstructive Pulmonary Disease Assessment Test will be used to determined symptoms in patients with COPD. The total score of Chronic Obstructive Pulmonary Disease Assessment Test changes from 0 to 40 points, and 10 points is the accepted cut-off point for COPD.
Diffusion capacity for patients with diffuse parenchymal lung diseases1 dayCarbon Monoxide Diffusion Capacity test with single breath method will be used for patients with diffuse parenchymal lung diseases.
Respiratory Muscle Strength1 dayRespiratory muscle strength will be assessed using a mouth pressure device according to American Thoracic Society/ European Respiratory Society guidelines.
Lung function1 dayLung function will be assessed via a spirometer according to American Thoracic Society/ European Respiratory Society guidelines.
Dyspnea1 dayDyspnea will be assessed via The Modified Medical Research Council. The Modified Medical Research Council consists of five grades. A higher grades represents severe dyspnea level.
Peripheral muscle strength1 dayPeripheral muscle strength will be assessed via hand dynamometer.
Lower extremity capacity1 dayOne minute sit to stand test will be used for lower extremity capacity.
Energy expenditure1 dayAn armband will be used to assess energy expenditure during six minute walk test.
Balance and Fall risk1 dayTime up and go test will be used to assess balance and fall risk
Tightness of muscle1 dayPectoralis minör, pectoralis majör, adductor and internal rotator muscles, sternocleidomastoideus, and trapezius muscle tightness tests will be performed during musculoskeletal examination using a tape.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAynur Demirel, PhD
aynur.demirel@hacettepe.edu.tr+905545295057
Backup ContactHidaye Yamikan, PT,MSc
hidaye.yamikan@hacettepe.edu.tr+905349898724

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026